wasn't sally doing oxy
Sally Kinrade's Overview- did I miss her leaving or am I msitaken as she was in on Esra watch?
12 july
The Tretinoin/TPM® clinical program is being overseen by our recently appointed Chief
Operating Officer (COO), Sally Kinrade, who is responsible for managing clinical
programs and all operational activities of the Company. Ms Kinrade has worked for
Glaxo Smith Kline (Aust) for 20 years with the last 15 in Senior Management positions.
She is a Registered Pharmacist and has been involved in the development of drugs from
concept through to market launch and consolidation. She has in depth knowledge of
clinical operations, both in project delivery and process quality improvement
Who is our current coo?.
Current
Board Director at ARCS Australia Ltd
Principal at Innervate Consulting
Past
Chief Operating Officer at Phosphagenics Ltd.
Head of Medical Collaborations (Oncology) at GlaxoSmithKline Australia
Medical Manager, Oncology at GlaxoSmithKline
see all
new ceo and board 'business model', page-26
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.32K | 440K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 40522233 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 40065430 | 31 |
View Market Depth
| Last trade - 14.05pm 15/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |